Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice.
Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, Hu X, Doi K, Vaisman B, Amar M, Sviridov D, Chen Z, Remaley AT, Csako G, Patterson AP, Yuen PS, Star RA, Eggerman TL.
Leelahavanichkul A, et al. Among authors: chen z.
J Immunol. 2012 Mar 15;188(6):2749-58. doi: 10.4049/jimmunol.1003445. Epub 2012 Feb 10.
J Immunol. 2012.
PMID: 22327076
Free PMC article.